Trade Summary

3 days ago, Ali-Jackson Kamil, serving as Dir at RIGEL PHARMACEUTICALS INC (RIGL), sold 2,500 shares at $29.17 per share, for a total transaction value of $72,925.00. Following this transaction, Ali-Jackson Kamil now holds 12,625 shares of RIGL.

This sale represents a 16.53% decrease in Ali-Jackson Kamil's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 26, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 28, 2026 at 4:19 PM ET, 2 days after the trade was made.

RIGEL PHARMACEUTICALS INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.